BACKGROUND: Several recent studies suggest that repetitive transcranial magnetic stimulation can temporarily reduce pain perception in neuropathic pain patients and in healthy adults using laboratory pain models. No studies have investigated the effects of prefrontal cortex stimulation using transcranial magnetic stimulation on postoperative pain. METHODS:Twenty gastric bypass surgery patients were randomly assigned to receive 20 min of either active or sham left prefrontal repetitive transcranial magnetic stimulation immediately after surgery. Patient-controlled analgesia pump use was tracked, and patients also rated pain and mood twice per day using visual analog scales. RESULTS: Groups were similar at baseline in terms of body mass index, age, mood ratings, pain ratings, surgery duration, time under anesthesia, and surgical anesthesia methods. Significant effects were observed for surgery type (open vs. laparoscopic) and condition (active vs. sham transcranial magnetic stimulation) on the cumulative amount of patient-delivered morphine during the 44 h after surgery. Active prefrontal repetitive transcranial magnetic stimulation was associated with a 40% reduction in total morphine use compared with sham during the 44 h after surgery. The effect seemed to be most prominent during the first 24 h after cortical stimulation delivery. No effects were observed for repetitive transcranial magnetic stimulation on mood ratings. CONCLUSIONS: A single session of postoperative prefrontal repetitive transcranial magnetic stimulation was associated with a reduction in patient-controlled analgesia pump use in gastric bypass surgery patients. This is important because the risks associated with postoperative morphine use are high, especially among obese patients who frequently have obstructive sleep apnea, right ventricular dysfunction, and pulmonary hypertension. These preliminary findings suggest a potential new noninvasive method for managing postoperative morphine use.
RCT Entities:
BACKGROUND: Several recent studies suggest that repetitive transcranial magnetic stimulation can temporarily reduce pain perception in neuropathic painpatients and in healthy adults using laboratory pain models. No studies have investigated the effects of prefrontal cortex stimulation using transcranial magnetic stimulation on postoperative pain. METHODS: Twenty gastric bypass surgery patients were randomly assigned to receive 20 min of either active or sham left prefrontal repetitive transcranial magnetic stimulation immediately after surgery. Patient-controlled analgesia pump use was tracked, and patients also rated pain and mood twice per day using visual analog scales. RESULTS: Groups were similar at baseline in terms of body mass index, age, mood ratings, pain ratings, surgery duration, time under anesthesia, and surgical anesthesia methods. Significant effects were observed for surgery type (open vs. laparoscopic) and condition (active vs. sham transcranial magnetic stimulation) on the cumulative amount of patient-delivered morphine during the 44 h after surgery. Active prefrontal repetitive transcranial magnetic stimulation was associated with a 40% reduction in total morphine use compared with sham during the 44 h after surgery. The effect seemed to be most prominent during the first 24 h after cortical stimulation delivery. No effects were observed for repetitive transcranial magnetic stimulation on mood ratings. CONCLUSIONS: A single session of postoperative prefrontal repetitive transcranial magnetic stimulation was associated with a reduction in patient-controlled analgesia pump use in gastric bypass surgery patients. This is important because the risks associated with postoperative morphine use are high, especially among obesepatients who frequently have obstructive sleep apnea, right ventricular dysfunction, and pulmonary hypertension. These preliminary findings suggest a potential new noninvasive method for managing postoperative morphine use.
Authors: Jeffrey J Borckardt; Scott T Reeves; Heather Frohman; Alok Madan; Mark P Jensen; David Patterson; Kelly Barth; A Richard Smith; Richard Gracely; Mark S George Journal: Pain Date: 2010-11-30 Impact factor: 6.961
Authors: David H Avery; Paul Zarkowski; Daniel Krashin; Wang-Ku Rho; Chandra Wajdik; Jutta M Joesch; David R Haynor; Dedra Buchwald; Peter Roy-Byrne Journal: J ECT Date: 2015-03 Impact factor: 3.635
Authors: Jeffrey J Borckardt; Scott T Reeves; Cole Milliken; Brittan Carter; Thomas I Epperson; Ryan J Gunselman; Alok Madan; H Del Schutte; Harry A Demos; Mark S George Journal: Brain Stimul Date: 2017-09-06 Impact factor: 8.955
Authors: Jeffrey J Borckardt; Scott T Reeves; Will Beam; Mark P Jensen; Richard H Gracely; Sophie Katz; Arthur R Smith; Alok Madan; David Patterson; Mark S George Journal: Clin J Pain Date: 2011 Jul-Aug Impact factor: 3.442
Authors: Joseph J Taylor; Jeffrey J Borckardt; Melanie Canterberry; Xingbao Li; Colleen A Hanlon; Truman R Brown; Mark S George Journal: Neuropsychopharmacology Date: 2013-01-11 Impact factor: 7.853
Authors: Jeffrey J Borckardt; John Walker; R Kyle Branham; Sofia Rydin-Gray; Caroline Hunter; Heather Beeson; Scott T Reeves; Alok Madan; Harold Sackeim; Mark S George Journal: Brain Stimul Date: 2008-01 Impact factor: 8.955
Authors: Jeffrey J Borckardt; Scott T Reeves; Mitchel Weinstein; Arthur R Smith; Neal Shelley; F Andrew Kozel; Ziad Nahas; Karl T Byrne; Katherine Morgan; Mark S George Journal: Brain Stimul Date: 2008-04 Impact factor: 8.955